DE GRAEF Pieter
DE GRAEF Pieter, EMEA, NED<br>He was born in 1950 and finished medical training at the University of Groningen in 1975. Following a training in internal medicine at the department op Internal Medicine of the UMCG he was registered as an internist in January 1983. Subsequently, he became a clinical advisor for the MEB, maintaining a position as associate professor at the depts. of Internal Medicine and Pharmacology/Clinical Pharmacology. In 1989 he finished his thesis (PhD), In 1994 he was co-registered as a clinical pharmacologist. In 1996 he became professor in pharmacotherapeutics, responsible for implementing rational pharmacotherapy. In 2003 he was elected as “teacher of the year”. He maintained a part-time position as senior clinical adviser of the MEB as head of the regulatory cardiovascular subdivision. In 2007 he became member of the CHMP and in 2012 of the Dutch MEB. He has fulfilled a number of positions at various organisations, among which the cardiovascular subgroup WP of the EMA
(since 1999 member, since 2011 chairman), the hospital
Medical Ethics Committee, the hospital Pharmacotherapy
Committee, and the Board of the Dutch Society Clinical Pharmacology & Biopharmaceutics (chairman 1996-2000). He (co-)authored more than 100 publications in peerreviewed journals. He was involved in writing a number of regulatory cardiovascular guidelines, including those on antihypertensive, lipid-lowering and anti-arrhythmic agents.